Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
... in different animal models of
acute and severe
optic nerve injury. In collaboration with Prof. Ann ... a model of
retinal ganglion cell (RGC) death by
optic nerve crush (ONC). In a second
study of QPI-1007 ... in a model of RGC death induced by axotomy of
the
optic nerve. QPI-1007 displayed neuroprotective ...
Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
... The imager was developed using Tower's advanced sensor design and
production technologies, while the camera was developed using Medigus'
electronic,
optic and integration platform technologies. The camera features
dedicated bio-compatible components suitable for medical device applications
and will ...
R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
... demonstrates steady ocular pressure-decreasing action by twice-a-day instillation. Such excellent therapeutic effects are realized through its
optic nerve protection and ocular blood flow-increasing mechanism. Concerning Rescula(R) (isopropyl unoprostone) for the treatment of glaucoma and ocular ...
Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
... of clinical symptoms and/or radiographic evidence of demyelinating disease. Rare cases of neurological disorders, including seizure disorder,
optic neuritis, and peripheral neuropathy have been reported in patients treated with CIMZIA; the causal relationship to CIMZIA remains unclear. Exercise ...
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
... myocardial infarction, angina, pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity,
optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness; neutropenia, infection (sepsis, pneumonia, abscess, ...
Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
... pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular edema and retinal thrombosis/hemorrhages,
optic neuritis and papilledema).
Adverse reactions reported during post-approval use of PEGASYS therapy, with and without ribavirin, include hearing ...
Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
... pancreatitis, and ophthalmologic disorders (decrease or loss of vision, retinopathy including macular edema and retinal thrombosis/hemorrhages,
optic neuritis and papilledema). Adverse reactions reported during post-approval use of PEGASYS therapy, with and without ribavirin, include hearing ...
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients
... myocardial infarction, angina, pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity,
optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness; neutropenia, infection (sepsis, pneumonia, abscess, ...
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
... myocardial infarction, angina, pericardial effusion, retinal ischemia, retinal artery or vein thrombosis, blindness, decreased visual acuity,
optic neuritis, transient ischemic attack, supraventricular arrhythmias, loss of consciousness; neutropenia, infection (sepsis, pneumonia, abscess, ...
Quark Pharmaceuticals Presents at Asia TIDES Conference
... to operate in the siRNA IP space. QPI-1007 is in advanced IND-enabling preclinical studies for the treatment of non-arteritic anterior ischemic
optic neuropathy and has demonstrated proof-of-concept efficacy as a neuroprotective agent in animal models of eye diseases .
Dr. Thompson ...
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
... of bleb formation.
Adverse reactions associated with ophthalmic steroids include elevated
intraocular pressure, which may be associated with
optic nerve damage,
visual acuity and field defects, posterior subcapsular cataract formation,
secondary ocular infection from pathogens including herpes ...
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
... of clinical symptoms and/or radiographic
evidence of demyelinating disease. Rare cases of neurological disorders,
including seizure disorder,
optic neuritis, and peripheral neuropathy have
been reported in patients treated with CIMZIA; the causal relationship to
CIMZIA remains unclear. Exercise ...
Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
... of bleb formation.
Adverse reactions associated with ophthalmic steroids include elevated
intraocular pressure, which may be associated with
optic nerve damage,
visual acuity and field defects, posterior subcapsular cataract formation,
secondary ocular infection from pathogens including herpes ...
CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients
... of clinical symptoms and/or radiographic
evidence of demyelinating disease. Rare cases of neurological disorders,
including seizure disorder,
optic neuritis, and peripheral neuropathy have
been reported in patients treated with CIMZIA; the causal relationship to
CIMZIA remains unclear. Exercise ...
Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
... of bleb formation.
Adverse reactions associated with ophthalmic steroids include elevated
intraocular pressure, which may be associated with
optic nerve damage,
visual acuity and field defects, posterior subcapsular cataract formation,
secondary ocular infection from pathogens including herpes ...
CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
... of clinical symptoms and/or radiographic
evidence of demyelinating disease. Rare cases of neurological disorders,
including seizure disorder,
optic neuritis, and peripheral neuropathy have
been reported in patients treated with CIMZIA; the causal relationship to
CIMZIA remains unclear. Exercise ...
Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
... including HUMIRA, have been associated in rare cases
with demyelinating disease including multiple sclerosis, Guillain-Barre
syndrome and
optic neuritis, and serious allergic reactions. Rare reports
of pancytopenia including aplastic anemia have been reported with
TNF-blocking agents. Adverse ...
Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
... trial. It will involve more than 600 patients considered at
risk of developing MS due to a recently experienced isolated demyelinating
event (e.g.
optic neuritis, myelopathy or brainstem syndrome) and having
MRI brain scans consistent with early signs of MS. Study participants will
be randomized in ...
Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
... valuable insights."
A total of 517 patients considered at risk of developing MS due to a
recently experienced isolated demyelinating event (e.g.
optic neuritis,
myelopathy or brainstem syndrome) and having magnetic resonance imaging
(MRI) brain scans consistent with early signs of MS have been ...
Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System
... working channel
through which diagnostic and therapeutic devices can be used in the biliary
ducts. The system includes a miniature 6,000-pixel fiber
optic probe
attached to a camera that provides physicians with a direct view of a
patient's bile ducts, overcoming some of the visual challenges ...
Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease
... of clinical symptoms and/or radiographic
evidence of demyelinating disease. Rare cases of neurological disorders,
including seizure disorder,
optic neuritis, and peripheral neuropathy have
been reported in patients treated with Cimzia(R); the causal relationship
to Cimzia(R) remains unclear. ...
PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C
... pancreatitis, and ophthalmologic disorders (decrease or loss of
vision, retinopathy including macular edema and retinal
thrombosis/hemorrhages,
optic neuritis and papilledema). Adverse reactions
reported during post-approval use of PEGASYS therapy, with and without
ribavirin, include hearing ...
Prism Glasses Expand the View for Patients with Hemianopia
... than a million Americans suffer from hemianopia, which blinds the
vision in one half of the visual field in both eyes, resulting from damage
to the
optic pathways in the brain. Most commonly caused by strokes, it can
also be the result of brain damage from tumors or trauma. A patient with
this ...
Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
... and visual function. Current
studies in the F.M. Kirby Center include evaluations of the molecular
genetics and pathogenetic mechanisms involved in
optic nerve disease and
inherited retinal and macular degenerations, cell biology studies of
photoreceptor sensory cilia, delineation of mechanisms ...
FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.
... exposure within the ocular compartment is below the clinical
threshold of observable tissue damage for all structures including the
lens,
optic disc, and retina. Importantly for patients, the systemic
exposure to radiation is minimal, as the effective dose to the entire body
from NeoVista's ...
New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
... eye develops a tumor. Scientists do
not yet know why these sporadic mutations occur. If left untreated, the
tumors can spread to the brain via the
optic nerve. One-half of the
children in the world who develop this cancer will die.
About Intra-arterial Chemotherapy
Each interventional ...
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
... reported adverse events with
LEVITRA were headache, flushing, and rhinitis. Adverse events were
generally transient.
Nonarteritic anterior ischemic
optic neuropathy (NAION) has been
reported rarely postmarketing in temporal relationship with the use of PDE5
inhibitors, including LEVITRA. Sudden loss of ...
CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
... medical device company based in
Marlborough, Massachusetts. The company is developing, manufacturing and
investigating proprietary, disposable fiber
optic catheters for the
visualization of the cardiac anatomy and the treatment of cardiac
arrhythmias such as atrial fibrillation. For more information, ...
Data Published in Neurology Showed That Higher Dose of Copaxone
Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
... people are affected worldwide. MS is a progressive,
demyelinating disease of the central nervous system affecting the
brain, spinal cord and
optic nerves.
Patients with MS may experience physical symptoms and/or
cognitive impairments, including weakness, fatigue, ataxia,
physical dysfunction, ...
Data on Higher Dose of Copaxone and Data Showing Copaxone is Most
Cost Effective
... people are affected worldwide. MS is a progressive,
demyelinating disease of the central nervous system affecting the
brain, spinal cord and
optic nerves.
Patients with MS may experience physical symptoms and/or cognitive
impairments, including weakness, fatigue, ataxia, ...
Laquinimod, a Novel Oral Compound, Showed Significant Reduction in
Disease Activity in Patients with Relapsing-Remitting Multiple
Sclerosis (RRMS)
... people are affected worldwide. MS is a progressive,
demyelinating disease of the central nervous system affecting the
brain, spinal cord and
optic nerves.
Patients with MS may experience physical symptoms and/or
cognitive impairments, including weakness, fatigue, ataxia,
physical dysfunction, ...
Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple
Sclerosis Presented at the American Academy of Neurology
... system is thought to attack the body's
own myelin, a fatty substance that surrounds and protects the nerve
fibers of the brain, spinal cord and
optic nerves. There are four
types of MS with a wide variety of symptoms and different courses
of disease progression. RRMS is the most common form of ...
Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple
Sclerosis Presented at the American Academy of Neurology
... system is thought to attack the body's
own myelin, a fatty substance that surrounds and protects the nerve
fibers of the brain, spinal cord and
optic nerves. There are four
types of MS with a wide variety of symptoms and different courses
of disease progression. RRMS is the most common form of ...
Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA
Nanoparticles
... treatments for more complex disorders such as
diabetic retinopathy, macular degeneration, and various diseases
that injure ganglion cells and the
optic nerve."
"We are pleased by the promise of these results and look forward
to moving these studies forward to a potential human clinical
trial," ...